ABSTRACT. Lactoferrin (Lf) is a major iron (Fekbinding presence of substances enhancing Fe absorption from human protein in human milk and has been proposed to facilitate milk.
I N ET AL. (9) . The results from these studies are difficult to interpret in relation to breast-fed human infants.
The present study was designed to investigate the influence of Lf on Fe absorption from human milk in infants. Fe absorption was measured from human milk in breast-fed infants I ) with the native level of Lf present and 2) after removal of >97% of the Lf. The study had a randomized, cross-over design and Fe absorption was measured by stable isotope technique, using 58Fe as a label, with Fe absorption measured by analysis of the incorporation of "Fe into red blood cells 14 d after administration.
MATERIALS AND METHODS
Subjects. Mothers with healthy term infants were recruited via advertisements in local papers or via pediatricians in the area. The parents were fully informed about the aims and procedures of the study and consent forms were signed by each mother before enrollment in the study. All infants were breast-fed although the older infants were given small portions of solid foods (cereals, fruits, etc.). However, during the Fe absorption study no other foods or fluids than labeled breast milk were given. Four girls and four boys were recruited for the study. Mean birth weight was 3576 g (range, 3062-3856 g). Mean age at enrollment in the study was 5 mo (range, 2-10 mo).
The protocol was approved by the Human Subjects Committee at the University of California at Davis.
Collection of Breast Milk. Breast milk was expressed by using either a manual (Comfort Plus, Kaneson breast pump, Omron Marshall Products Inc., Lincolnshire, IL), an electric breast pump (Gerber Products Company, Fremont, MI) or a Medela breast pump (Medela Inc., Crystal Lake, IL). All parts of the pumps being exposed to the breast milk were washed with hot water and a mild detergent followed by rinsing with ultra pure water (17.5 MS1; Sybron, Barnstead, MA) between usage. Expressed milk was stored at -20°C in sterile disposable bottles (Playtex Family Products Corp., Dover, DE) until the requested total volume of approximately 2 L of milk was obtained. Some mothers were not able to produce this amount of milk and a smaller quantity was therefore administered to their infants. The volume of labeled milk was, however, kept constant at the two administrations for each infant. The total time period for collecting the milk was at most 3 wk and all infants were nursed during this time.
Manual and small electrical breast pumps as well as sterile bottles, ultrapure water, and detergent were provided during the study.
Preparation of Lf'free Breast Milk. All milk expressed by each mother was thawed and pooled in a sterile plastic container. The total weight was registered and the milk was separated into two equal parts. One part was labeled with "Fe without any further modifications ("breast milk"), whereas the other part was treated with heparin-Sepharose gel to remove Lf ("Lf-free breast milk") (Fig, 1) .
Lf-free breast milk was prepared by addition of heparinaepharose CL-6B gel (Pharmacia LKB Biotechnology, Piscataway, NJ). Aliquots (200 g) of milk were centrifuged in 250 mL previously autoclaved centrifuge bottles at 4°C and 4068 x g for 30 min using a Sorvall GSA rotor (Sorvall RC-5B, DuPont Instruments, Wilmington, DE). Fat was removed with a plastic spatula, weighed, and kept frozen. To each defatted milk fraction remaining in the centrifuge bottles, 10 g (freeze-dried weight) heparin8epharose were added. Each 10-g aliquot of gel had been previously washed according to the manufacturer's instructions in 200 mL of ultrapure water per gram of freeze-dried gel. The washed gel was allowed to swell in ultrapure water for approximately 15 min before addition to the defatted milk fraction. The defatted milk/gel mixture was left at 4°C under gentle shaking conditions overnight. The gel was then removed by centrifugation (366 x g, 4°C for 15 min) followed by filtration through four layers of cheese cloth into a preweighed sterile plastic bottle. The total weight of defatted milk was registered; a very small amount (3-4% of total weight) was lost during the treatment.
The completeness of the Lf removal from the milk was controlled immediately after the treatment by SDS-PAGGE (10-20% plates, Daiichi Pure Chemicals Co. Ltd., Tokyo, Japan) followed by Western blotting. Proteins were transferred to nitrocellulose paper (pore size 0.2 pm, Schleicher & Schuell, Keene, NH) in 0.02 M TrisBase/O. 15 M glycine buffer (pH 8.3) by using a transfer electrophoresis unit (Hoefer Scientific Instruments, San Francisco, CA) at 200 mA. Rabbit anti-human Lf (Dako, Copenhagen, Denmark) was used as the primary antibody and goat anti-rabbit IgG alkaline phosphate conjugate (Bethesda Research Laboratories, Gaithersburg, MD) as the secondary antibody. Untreated breast milk from the same mother was used as the reference. The concentration of Lf in the milk samples was measured quantitatively by ELISA. Rabbit anti-human Lf (Dako) was used as the primary antibody and goat-anti rabbit IgG alkaline phosphate conjugate (Bethesda Research Laboratories) as the secondary antibody for both Western blot and ELISA.
Lf was removed from the heparin-Sepharose by washing with 4 volumes of 2 M NaCl. Thereafter, the gel was washed with 5 vol ultrapure water, vacuum-filtered, and kept stored at 4'C in 20% ethanol. Before being reused, the gel was again washed with 5 vol ultrapure water and autoclaved at 100°C for 10 min in 5 vol of water. Each gel was recycled two to three times.
Total protein content of milk samples was determined colorimetrically by the BioRad method (BioRad Protein Assay, BioRad Laboratories, Richmond, CA). The Fe content of breast milk and Lf-free breast milk was measured on freeze-dried aliquots by GFAAS, using model 975 AAS (Varian Techtron, Mulgrave, Australia) equipped with a GTA-95 graphite furnace and an autosampler. Milk samples were wet ashed in a microwave digestion system (MDS-8 1 D, CEM corporation, Matthews, NC) using lined digestion vessels (maximum operating pressure 1380 kPa). A two-step digestion procedure was used. Approximately 200 mg of sample were heated with 5 mL of concentrated HNO3 for 14 min, followed by venting the bombs. After addition of 2 mL of H202 (Merck, Darmstadt, Germany), samples were microwaved again and thereafter the clear digest was transferred to Teflon tubes and evaporated to dryness under filtered N2.
Samples were redissolved in 0.1 M HN03 before GFAAS measurement. Pyrolytically coated graphite tubes (Varian Tech-tron) were used. The furnace program included chamng at 600°C and atomization at 2300'C. Measurements were done in the peak mode, using deuterium background correction. Standard addition was not used because comparison of measurements with external calibration against standards in 0.1 M HN03 and standard addition gave the same results. Recovery of added Fe was found to be 99%. Analysis of blank samples showed reproducible results; a mean blank value of 22 f 5 ng (n = 9) was found. The detection limit for Fe was 0.27 nmol (15 ng), calculated from 3 times SD of the blank value. Precision for triplicate analysis of milk samples was 4.5%. A reference material (Skim Milk Powder, BCR 63, Community Bureau of References, Brussels, Belgium) was analyzed together with the milk samples. A value of 0.031 f 0.0007 pmollg (1.71 k 0.04 pg/g) (n = 9) was found. This is somewhat lower than the certified value 0.037 f 0.004 pmol/g (2.06 * 0.25 pg/g).
Only Teflon and polyethylene containers were used and all material was rigorously cleaned by soaking in 1 M HN03 for 24 h, followed by rinsing with ultrapure water (18 Ma, Millipore AG, Zurich, Switzerland). Nitric acid was cleaned by sub-boiling distillation whereas H202 was suprapure quality. Sample preparation was done in a laminar flow hood. After each digestion, Teflon vessels were cleaned twice with 20 mL of 7 M HN03 by heating in the microwave oven for 10 min. A blank value was measured from each vessel before reusing it.
Stable Isotopes. Stable isotopes of Fe (57Fe and "Fe) were purchased from Medgenix Diagnostics (Dusseldorf, Germany) as metallic Fe. The isotopic composition of the 58Fe label was 93.31% "Fe, 6.54% 57Fe, and 0.154% 56Fe and 95.30% 57Fe, 2.37% 58Fe, and 2.34% "jFe for the 57Fe label. The metallic "Fe was dissolved in sulfuric acid to obtain "FeS04. The 57FeS04 was prepared according to the method described earlier (29) . Solutions containing 12.2 and 6.52 mmol of total Fe/L were made up for 57Fe and 58Fe, respectively. Ascorbic acid (1 1.8 mmol/L) was added to the 57Fe solution whereas no addition of ascorbic acid was made to the 58FeS04 solution. Portions equivalent to one reference dose (50.2 pmol; 2.86 mg 57Fe) or enough "Fe to label the two batches of milk per infant (1 8.3 pmol; 1.06 mg "Fe in 3 mL of solution) were filled into sterile glass ampules, purged with nitrogen, and sealed. The ampules were stored at 4'C in the dark until used.
Labeling of Milk Samples with Stable Isotopes. As part of the Fe absorption technique, a total amount of 8.6 pmol(0.5 mg) of 58Fe had to be added to each batch of milk followed by freezing until administered. Three preliminary studies were made to I ) determine the optimum time at which the added Fe has the same distribution in the milk as native Fe, 2) to determine the effect of freezing on the distribution of added Fe, and 3) to determine the distribution of added Fe in the whey fractions from breast milk and Lf-free breast milk.
Optimum time for equilibration. Two aliquots (20 mL) each of Lf-free breast milk and untreated breast milk were labeled with 11 kBq of 59Fe (NENIDupont, Wilmington, DE; sp act 2 120 MBq/mg as femc chloride). Also, FeS04 (Fisher Scientific, Fairlawn, NJ) was added in a quantity equivalent to 9.0 pmol (0.5 mg) Fe/L to one sample (20 mL) each of Lf-free breast milk and breast milk and the milks were shaken gently at 4°C. Aliquots (5 mL) were removed at 24, 48, and 72 h. The distribution of the radioisotope in the lipid, whey, and pellet fractions was determined by gamma counting (Gamma 8500, Beckman Instruments Inc., Fullerton, CA) after ultracentrifugation at 242 700 x g for 30 min (Sorvall ultracentrifuge OTD65B, Dupont Instruments).
Effect offreezing on distribution of added Fe. Aliquots (5 mL) of untreated breast milk and Lf-free breast milk equilibrated for 24 h with added 59Fe and FeS04 (prepared as described above) were frozen at -20'C for 1, 2, 3, and 4 wk. At each time point, samples from the milks were thawed and the distribution of 59Fe measured.
Distribution of Fe in the whey fractions. FPLC (Pharmacia Fine Chemicals, Piscataway, NJ) was used to determine the distribution of the added Fe in the whey fractions from the above experiments. After ultrafiltration, whey fractions from breast milk and Lf-free breast milk were filtered (0.2 and 0.45 pm, Acrodisc syringe filters, Gelman Sciences, Ann Arbor, MI) and 1.0 mL was injected into the gel filtration column (Superose 12, Pharmacia). The running buffer was 20 mM ethanolamine with 0.3 M NaCl, degassed and filtered through 0.22 pm filters (Millipore Corp., Bedford, MA). The flow rate was l mL/min and peaks were monitored at 280 nm. Eluted fractions were measured for their content of radioactivity by gamma counting and pooled fractions (containing the major part of the 59Fe) were further evaluated by SDS-PAGGE (10-20% gels). Citrate (Sigma, St. Louis, MO) prepared as 50 mM solutions with pH 2.38 and 7.00, respectively, was also separated by FPLC (after addition of 11 kBq 59Fe) and eluted fractions were measured by gamma counting.
Labeling of Milk for the Fe Absorption Study.
A preweighed ampule of "Fe was opened, the content divided into two equal parts using sterile syringes, and identical volumes of isotope solution were added to each batch of breast milk and Lf-free breast milk. The two batches of milk for each infant were always labeled at the same time and with the same amount of added Fe. Before addition of the isotope solution, the fat from each defatted milk fraction of the Lf-free breast milk was replaced.
The labeled milks were left at 4°C and gently stirred for 24 h to enable the added Fe to equilibrate with the native Fe. Feeding portions were made by weighing labeled milk into sterile disposable bottles (Playtex Family Products Corp.) according to each mothers' estimate of amounts required for a single feed. The size of the portions varied according to the infant's age, but were in the range of 1 15 to 155 g per bottle. Each bottle was labeled with the infants' code and A or B for Lf-free breast milk and breast milk, respectively. The feeding portions were kept frozen until administered.
Administration of Labeled Milk. The infants were randomly assigned to be fed either Lf-free breast milk or breast milk during the first administration of labeled milk in the study. The individual bottles were thawed in warm tap water immediately before the infants were fed. Mothers were instructed not to use microwave ovens or excessively hot water for heating the milk. The study was carried out in the homes with either one of the parents or the regular baby-sitter feeding the infant. Most babies were fed by their parents and in case of having the baby-sitter feeding the labeled milk, special care was taken to make sure that this person was informed about the study protocol. No other food or fluid was allowed during the administrations of labeled milk. The administration started in the morning at the normal time of the first feed of the day and only labeled breast milk was given until all the labeled milk in each batch had been consumed (approximately 24 h). The mothers were closely supervised as how to feed the milk, to keep records of feeding times, and to save all used bottles in the freezer to be weighed later. Preweighed bibs and disposable wipes were provided during the administrations to estimate losses during the feeds. The use of bibs and wipes was registered and all used material was kept frozen until thawed and weighed. The second batch of labeled milk was administered, under identical conditions, approximately 15 to 16 days after intake of the first batch.
Reference Dose. A reference dose consisting of 50.2 pmol(2.86 mg) of 57Fe (as FeS04) was administered on the day after each administration of labeled milk. The reference dose was prepared immediately before each administration by opening a preweighed ampule, adding 0.62 mmol (123 mg) of sodium ascorbate (Lascorbic acid sodium salt, A-763 1 Lot 90H0667, Sigma) and 630 mg of sucrose (cane sugar) and mixing the contents by drawing portions of the solution into a sterile syringe with an 18-gauge needle and returning it to the ampule several times. The solution (5 mL) was weighed into two sterile 3-mL syringes that were used to administer the dose directly into the infant's mouth.
IN ET AL.
Syringes were weighed before and after administrations to calculate the dose given to each infant. Preweighed bibs and wipes were used to collected rejected solution.
Blood Samples. Venous blood samples (total volume 2-3 mL) were drawn at local clinical laboratories before each administration of labeled milk and 14 d after intake of each reference dose. Whole blood was used to determine the isotope ratios 57Fe/56Fe and 58Fe/'6Fe, whereas serum samples were obtained for analysis of serum Fe, total Fe binding capacity, and femtin. Hemoglobin was analyzed at the clinical laboratories using routine technique. Serum Fe and total Fe binding capacity were analyzed by a colorimetric method (Sigma kit no. 565-A, Sigma Diagnostics), whereas femtin was determined by an enzyme immunoassay (Medix Biotech kit MB-1053, Medix Biotech Inc., Foster City, CA).
Analysis of Stable Isotopes in Blood Samples. One baseline and two enriched blood samples were analyzed per infant for their isotopic composition. The method used for sample preparation and analysis has been described in detail elsewhere (29) . Isotope ratios were measured by thermal ionization mass spectrometry (Finnigan MAT model THQ, Bremen, Germany), after loading samples onto rhenium filaments.
Iron absorption was calculated based on the enrichment of "Fe and "Fe in red blood cells measured 14 d after administration. Corrections for enriched baseline values were made when calculating Fe absorption from the second labeled test meal as well as for the second reference dose. Fe absorption was calculated based on an assumed blood volume (65 mL/kg) and incorporation of 90% of absorbed Fe into red blood cells (29) .
Percentage absorption values were converted to logarithms for statistical analysis and the results were reconverted to the antilogarithms to recover the original units (30) .
Statistics. Paired t test was used when comparing Fe absorption from breast milk to Lf-free breast milk as well as to compare Fe absorption from the two reference doses.
RESULTS

Labeling of Milk Samples with Stable
Isotopes. Optimum equilibration time. The distribution of added "Fe in milk samples (breast milk and Lf-free breast milk) after different equilibration times showed only minor differences between samples with native Fe present as compared to milk with added FeS04 (Table  1) . With increasing labeling time, 59Fe moved from the whey fraction into the fat layer. For practical and hygienic reasons, a labeling time of 24 h was chosen when preparing labeled milk for the Fe absorption study.
Effect offreezing. Information from the study of the effect of freezing on distribution of added Fe also shows a tendency toward increased amounts of 59Fe moving from the whey compartment into the fat fraction during storage at -20°C (Fig. 2) . However, the differences in the distribution of added Fe isotope were small. To avoid a systematic error in distribution of added Fe isotope during the Fe absorption study, the administration of labeled milk was randomized. Distribution of Fe in whey. When whey samples from breast milk and Lf-free breast milk were separated by FPLC the mean fraction of 5qFe that coeluted with citrate was 32 and 52%, respectively.
Fe absorption study. Data on sex, age, body weight, and indices of Fe status for each infant at the time of the first blood sample are given in Table 2 . All infants were judged to have normal Fe status, except for one slightly low Hb (baby B) and one femtin value <12 pg/L (baby G). Concentrations of Fe, Lf, and total protein in the milk samples from each mother (breast milk and Lf-free breast milk, respectively) are shown in Table 3 . The removal of Lf from each batch of Lf-free breast milk was checked by SDS-PAGGE and Western blots. In each case only traces of Lf remained and the results from the ELISA assay confirmed that >97% of the total Lf was removed from all milk samples (Table 3) . In most samples, the remaining Lf content was < 1 % of the value in untreated milk. Mean (fSD) concentration of Lf was 1. The amount of labeled milk ingested as well as intake of "Fe for each child is given in Table 4 . Total volume of labeled milk varied between 700 and 1000 g/administration, but the volume was held constant between administrations for each infant. The intakes given in Table 4 demonstrate a consumption of 93 f 6 and 94 f 3% of the total volume labeled milk for breast milk and Lf-free breast milk, respectively. All infants, with the excep tion of baby H, received a dose of 8.6 pmollL (0.5 mg) "Fe per administration. Baby H received double the dose at both administrations.
Absorption of Fe was found to be significantly ( p < 0.05) higher when Lf-free breast milk was fed, as compared to breast milk. The geometric mean absorption (range) was 11.8 (3.4-37.4)% for breast milk and 19.8 (8.4-72.8)% when Lf-free breast milk was fed ( Table 5) . Absorption of Fe from the reference dose was 24.3 (14.8-47.7)% when given after intake of breast milk and 22.4 (1 1.4-47.3)% when given after intake of Lf-free breast milk (Table 5) . These values were not significantly different.
DISCUSSION
Our study does not show any enhancing effect of Lf on Fe absorption from breast milk in this age group of breast-fed infants. On the contrary, an inhibitory effect of Lf was demonstrated because Fe absorption was significantly lower when Lf was present as compared to Lf-free breast milk. These results are in agreement with some earlier studies in which an inhibitory effect of Lf on Fe-absorption has been demonstrated after introduction of purified human Lf into the duodenum of adult subjects (31) and after addition of human Lf to "simulated human milk" at a concentration similar to that of breast milk (9) . It is interesting to note, however, that in the youngest infant studied, Fe absorption was higher from human milk than from Lf-free breast milk. The hypothesis raised earlier by Brock (32) , that the biological role of Lf changes from early to late infancy may therefore still be valid.
The results from our study also showed a relatively low frac- tional Fe absorption from breast milk, with a mean value of 1 1.8%. Earlier studies in infants have reported Fe absorption (or retention) from breast milk to be in the range of 49 to 8 1 % (5-7). Studies in adult subjects have also demonstrated relatively high fractional Fe absorption from human milk; mean values were 2 1 (8), 15 (9) , and 48% (10). However, the study design used in the previous studies in infants make the interpretation of the results somewhat difficult. In the study by Saarinen et al. (7) the radioisotope ('9Fe) was administered as a solution into the mouth of the infants during a feed of breast milk. Fe absorption from human milk was reported to be 48.8 & 7.9%. In the second part of the same study, Fe absorption from an isotope solution was measured, without any food present in infants usually fed either human milk or cow's milk formula. Fe absorption was 38.1 + 6.5% when measured in breast-fed infants and 19.5 f 5.2% in formula-fed babies. The results in the first study could have been influenced by the lack of equilibration between the isotope and the native Fe. In the second part of the study, the Fe absorption values measured without any food may more reflect Fe status of the infants, and not Fe absorption from human milk or formula. Furthermore, the data reported by Saarinen (5) and Gamy (6) on estimated Fe absorption from breast milk was generated using an indirect method based on calculated changes in total body Fe over a period of time. This methodology is based on measured changes of Fe status (Hb and femtin) and estimated intakes of Fe and includes certain potential errors (e.g. the Fe content in human milk was assumed to be 17.9 pmol/L; 1 mg/L). Finally, the absorption study by Hallberg et al. (10) is not likely to take into account any effect of Lf as this protein is likely to be completely digested in adults. An important feature of our study was that we measured Fe absorption from a relatively large quantity of labeled human milk (700-1000 g), administered in several feeds over a period of approximately 24 h, whereas earlier studies have used smaller test meals, i.e. single meals (7) (8) (9) (10) . The effect of the meal size on Fe absorption has been demonstrated earlier in rhesus monkeys who absorbed a larger fraction of Fe when the size of the test meal was reduced (25) . The value for Fe absorption from human milk obtained in our study thus probably reflects more closely Fe absorption under normal feeding conditions. The relatively low fractional Fe-absorption found by us might reflect the low need for Fe early in life when the infant can still utilize Fe stores accrued during fetal life. Lf levels are highest in milk of humans and guinea pigs, both of whose young grow notably slower than those of other species of comparable size and the need for exogenous Fe will therefore be lower (32) . Thus, Lf may still have an important role in controlling Fe absorption in the very young child. Based on our data (Table 5) fractional Fe absorption seems to increase with age because the older infants absorbed a larger fraction of the Fe present in human milk than the younger infants. However, the number of infants studied is too small to draw any conclusions on the effect of age on Fe absorption. In addition, Fe status also varied with age, i.e. the oldest infant had very low storage Fe (femtin) and the youngest infant had higher stores.
When discussing the results from our study, several points need to be addressed in relation to the data generated. The removal of Lf, the study design and the stable isotope methodology including the labeling technique all have to be considered as potentially influencing the results. Lf was removed by using heparin8epharose which binds Lf specifically (33) . This method was considered as the most suitable technique to remove Lf without introducing any other major modifications of the milk. Heat treatment of human milk does inactivate most of the Lf but also leads to modifications of the milk by denaturation of other proteins, e.g. immunoglobulins (34) . A study design including paired comparisons is essential when evaluating the influence of dietary components on Fe absorption in infants (35) . In the present study we included, apart from the paired comparison, administration of a reference dose as close in time as possible to each intake of labeled milk. Fe status in itself affects Fe absorption and we wanted to make sure that no such changes occurred during the time span of the study. No significant differences were found between the two administrations of reference doses, providing support for the notion that Fe status (or Fe absorption) did not change during this time.
Because fractional Fe absorption is generally low, the chemical balance technique is not a useful approach. Due to the risk involved, radioisotopes are often not permitted in studies of infants. A better alternative, especially in infants, is to use a stable isotope technique as this methodology does not impose any radiation risk for the participating subjects. Stable isotope techniques for studies of Fe absorption in infants have previously been developed by Fomon et al. (35) and by Kastenmayer et al. (29) . Their main disadvantage is that unlike the radioisotope technique, a significant quantity of Fe is added to the food as a label. It is especially important in studies where the test meals contain very small amounts of native Fe, e.g. human milk as addition of the isotope contributes significantly to the total Fe content in the diet fed. In the present study we kept the amount of added Fe as low as possible by choosing the Fe isotope with the lowest natural abundance (S8Fe), added in a highly enriched form. However, the increase of the total Fe content in the administered amounts of milk was in the range of 4-to 13-fold depending on the Fe concentration of milk from different mothers. The increase in Fe content was highest for baby H who received twice the dose of "Fe compared to the other infants. A decreased fractional absorption of Fe has been demonstrated with increasing dosage in studies of adult subjects (36) . Very little information is available on the effect of the Fe content of the meal on Fe absorption in infants. However, in adults it has been demonstrated that Fe in infant formula was absorbed to approximately 3% whether Fe was added as fortification Fe (2 15 pmol/ L; 12 mg/L), or present only as native Fe (9) . Thus, the effect of the increased content of Fe in the present study on the absorption of Fe from breast milk would not be expected to have a major impact on the results. In any case, the amount of added Fe was identical in the two test meals, and could therefore not explain the observed difference in Fe absorption between breast milk with and without Lf.
An important aspect when evaluating results from Fe absorption studies is the labeling technique. Intrinsic labeling, where the isotope is incorporated in vivo as an integral part of native Fe in the test meal is theoretically the most appropriate way of labeling test meals. However, this is a very tedious procedure, which in our case would have included several injections of 58Fe to the lactating mothers and collection of large milk volumes due to the expected very low enrichment of 59Fe in the milk (37) . In our study, we chose to use an extrinsic labeling technique, allowing a relatively long period of equilibration (24 h) to ensure distribution of the added "Fe equivalent to the distribution of native Fe in human milk. A labeling time consisting of 24 h was chosen, based on preliminary experiments as well as on practical considerations. This time period was considered as the maximum time for keeping human milk at 4°C when labeling the milk. In an earlier study (25) , equilibration times up to 72 h were demonstrated to be needed when labeling human milk with 59Fe. However, in the present study we found only minor differences in the distribution of 59Fe among different milk fractions when using labeling times between 24 and 72 h. Furthermore, no major difference was observed in the distribution of 59Fe in separate fractions of milk with and without Lf, either directly afier labeling or after storage at -20'C for up to 4 wk. Thus, the labeling technique chosen would not be expected to contribute to the difference observed in Fe absorption between breast milk and Lf-free breast milk.
Another aspect related to the labeling technique when using stable isotopes is the possible effect on Fe absorption that could be associated with changes in affinity of Lf to the receptor. The affinity of apo-Lf to the receptor is somewhat lower than that of mono-or diferric Lf (22) . Addition of Fe to human milk would lead to increased saturation of Lf, but not to a lower binding capacity to the receptor. The lower Fe absorption observed from the breast milk (containing Lf and added Fe) could therefore not be explained by lower affinity to the receptor. Human milk Lf is saturated with Fe to a low degree, only 3 to 5% of its capacity is used (38), binding approximately 30% of the total Fe (1 3). Low molecular weight ligands such as citrate are present in human milk in concentrations considerably higher than that of Lf. Equilibrium of the binding of Fe between citrate and Lf is therefore pushed toward the former ligand in human milk with normal composition (13) and likely even more so when Lf is removed. This was confinned in the present study.
Recently, a study of Fe absorption in piglets demonstrated that the extrinsic tag methodology is not valid for studies of sow's milk (37) . Extrinsic and intrinsic labeling of milk showed different distribution of the isotope between the fractions of fat, whey, and casein. The intrinsic label was mainly incorporated into fat, whereas extrinsically added isotope bound to casein. Fe retention measured in piglets was significantly higher from intrinsically labeled milk. However, sow's milk has a different composition as com~ared to human milk, e x . considerably higher casein conteniand because casein is dooiy digested by the young piglet this mipht ex~lain the low Fe absomtion from extrinsicallv labeled kilk. NO studies have been done to evaluate extrins; versus intrinsic labeling in studies of Fe absorption from human milk due to the difficulties involved in achieving adequate isotope enrichment in human milk.
The physiological role of Lf in breast milk remains unclear. In this study, we obtained no support for an enhancing effect of Lf on Fe absorption in infants 3 to 10 mo old. It is still possible that such a role may exist during early neonatal life. It is also possible that Lf may bind to the mucosa and exert an indirect effect on Fe absorption, for example by enhancing mucosal proliferation. Lf removal during a short period of time may then have no immediate effect on Fe retention. In addition, we know little about the regulation of Fe uptake and transfer across the mucosal cell. The existence of a highly specific receptor on the brush border membrane of the human infant intestine (1 8) may facilitate cellular uptake of Lf and Fe. This may in turn trigger intracellular events involved in regulation of Fe metabolism. It is also possible that the receptor is present to bind Lf and that any subsequent events are unrelated to Fe and its retention. Further studies at a cellular and molecular level are needed to answer some of these questions.
In conclusion, the mean Fe absorption from human milk was found to be relatively low, 1 1.8%, when studied in breast-fed infants. The absorption of Fe increased significantly when Lf was removed from the milk, resulting in a mean Fe absorption of 19.8%. The results from this study therefore do not support a role for Lf in increasing the Fe absorption from human milk.
